CN105341905A - Nutrient used for reducing weight and slimming - Google Patents
Nutrient used for reducing weight and slimming Download PDFInfo
- Publication number
- CN105341905A CN105341905A CN201510705682.0A CN201510705682A CN105341905A CN 105341905 A CN105341905 A CN 105341905A CN 201510705682 A CN201510705682 A CN 201510705682A CN 105341905 A CN105341905 A CN 105341905A
- Authority
- CN
- China
- Prior art keywords
- parts
- nutrient
- reducing
- weight
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 41
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical compound OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229910021536 Zeolite Inorganic materials 0.000 claims abstract description 13
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940089491 hydroxycitric acid Drugs 0.000 claims abstract description 13
- 239000010457 zeolite Substances 0.000 claims abstract description 13
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 11
- 229920002752 Konjac Polymers 0.000 claims abstract description 9
- 235000010485 konjac Nutrition 0.000 claims abstract description 9
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 12
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 12
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 12
- 244000013123 dwarf bean Species 0.000 claims description 11
- 235000021278 navy bean Nutrition 0.000 claims description 11
- 102000004407 Lactalbumin Human genes 0.000 claims description 9
- 108090000942 Lactalbumin Proteins 0.000 claims description 9
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 8
- 150000002515 isoflavone derivatives Chemical class 0.000 claims description 8
- 235000008696 isoflavones Nutrition 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 21
- 235000016709 nutrition Nutrition 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract 1
- 244000247812 Amorphophallus rivieri Species 0.000 abstract 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 abstract 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 abstract 1
- 244000046052 Phaseolus vulgaris Species 0.000 abstract 1
- 108010046377 Whey Proteins Proteins 0.000 abstract 1
- 102000007544 Whey Proteins Human genes 0.000 abstract 1
- 229940038481 bee pollen Drugs 0.000 abstract 1
- 239000000252 konjac Substances 0.000 abstract 1
- 235000003687 soy isoflavones Nutrition 0.000 abstract 1
- 235000021119 whey protein Nutrition 0.000 abstract 1
- 230000037396 body weight Effects 0.000 description 18
- 235000019197 fats Nutrition 0.000 description 18
- 230000036541 health Effects 0.000 description 17
- 210000002784 stomach Anatomy 0.000 description 11
- 239000002994 raw material Substances 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 125000001931 aliphatic group Chemical group 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 210000003470 mitochondria Anatomy 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 101710171801 Alpha-amylase inhibitor Proteins 0.000 description 3
- 206010033307 Overweight Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000003392 amylase inhibitor Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000004110 gluconeogenesis Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 229920002581 Glucomannan Polymers 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical group O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- -1 flavone compound Chemical class 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 229940046240 glucomannan Drugs 0.000 description 2
- 239000003163 gonadal steroid hormone Substances 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910052901 montmorillonite Inorganic materials 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 102100027211 Albumin Human genes 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000707825 Argyrosomus regius Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036772 Proctalgia Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 102000005686 Serum Globulins Human genes 0.000 description 1
- 108010045362 Serum Globulins Proteins 0.000 description 1
- 206010041969 Steatorrhoea Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 235000021407 appetite control Nutrition 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N cystine group Chemical group C([C@@H](C(=O)O)N)SSC[C@@H](C(=O)O)N LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 1
- 229960001243 orlistat Drugs 0.000 description 1
- 235000020825 overweight Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000001162 steatorrhea Diseases 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention relates to a nutritional product, and particularly relates to a nutritional product which is used for reducing weight and slimming. The present invention aims to provide a nutrient used for reducing weight and slimming with a good effect in reducing weight, but without any toxic side effects. The nutrient includes: 3-10 parts of bee pollen, 2-7 parts of white kidney bean essence, 6-12 parts of whey protein, 1-5 parts of soy isoflavones, 0.5-3 parts of L-carnitine, 2-6 parts of L-arabinose, 1-5 parts of hydroxycitric acid, 0.1-1 part of konjac dietary fiber and 0.5-3 parts of nano-zeolite. The use of the nutrient has a good effect in reducing weight, but has no toxic side effect. The nutrient is used in the weight-reducing and slimming field for obese people.
Description
Technical field
The present invention relates to a kind of dietetic product, particularly relate to a kind of dietetic product for weight-reducing.
Background technology
Along with Chinese society expanding economy, living standards of the people significantly improve, diet structure there occurs great variety, nutrient imbalance and variously provide the crops of human diet to use various toxin entrained by chemical fertilizer, agricultural chemicals, causes people's chronic disease and endocrinopathy, the fat key factor having become harm national health.
Show according to Chinese residents nutrition and health survey result, the minimizing that the excessive increase of China resident animal food and grease consumption and cereal, vegetables and fruit are consumed, make Energy intaking severe overweight, and dietary fiber, trace element insufficiency of intake, causes fat thus, the patient groups of hypertension, high fat of blood, diabetes is in increasing trend year by year.Announce according to " Data of Civil Constitution Monitoring method in 2010 ", more than the 18 years old overweight rate of resident in the whole nation is 30.6%, and obesity rates is 12%, and more than 18 years old resident's obese people reaches 1.2 hundred million.What follow is market has occurred a large amount of weight-reducing health foods.These product major parts do not go to research and produce according to obesogenous base reason, lack scientific.Current fat slim product is divided into several large class: 1. medicine control axis is neural, and make people not have hunger, fat-reducing effect is good, but the accumulation of drug toxicity, serious infringement health, the especially impariment of the liver, cause various hepatopathy, comprise more than cirrhosis, the millions of people of liver cancer; 2. Chinese medicine class fat-reducing, not only mouthfeel is bad, has little effect, in many patent documents and prescription for losing weight, with Chinese medicine compound l-cn, but Chinese medicine used is much cold and cool Chinese medicine, and the main cause of deficiency-cold in spleen and stomach, the deficiency of yang, the deficiency of vital energy, wet empty obesity just, therefore the scope of application is very limited; All physiological activities in addition in human body, it is all the result of matter interaction, l-cn is also the same, it plays a role under the functionss of hormones such as sex hormone, and the synthesis of sex hormone needs multiple unrighted acid to supply raw materials, if single edible l-cn effect is very limited; 3. edible " orlistat " weight reduction with drugs occupies significant proportion at present, but this medicine is non-prescribed medicine, arbitrarily use when there is no doctor's advice, still series of side effects can be produced, to defecate as occurred urgent sense, steatorrhea, incontinence of faces, stomachache, ventosity, proctalgia, headache, irregular menstruation, anxiety, fatigue, urethral infection etc.
Summary of the invention
The present invention is to solve the technical problem that existing diet products nutritional labeling is single, side effect is large, and a kind of fat-reducing effect provided is good, the nutrient for weight-reducing that has no side effect.It specializes in the instant of design, the fully nutrient of good mouthfeel mainly for the factor such as health of overweight crowd and the crowd that need reduce weight, and balancedly supplements the whole nutrition be suitable for required for crowd.Meanwhile people is eaten unnecessary fat, starch, carbohydrate and carbohydrate are got rid of external, and final purpose is weight-reducing while, improve the general level of the health of target group.
The present invention is used for the nutrient of weight-reducing, comprises Bee Pollen 3-10 part, navy bean essence 2-7 part, lactalbumin 6-12 part, isoflavones 1-5 part, l-cn 0.5-3 part, Arabinose 2-6 part, hydroxycitric acid 1-5 part, Konjak dietary fiber 0.1-1 part and nano zeolite 0.5-3 part according to mass fraction.
Further, the present invention is used for the nutrient of weight-reducing, comprises Bee Pollen 5-8 part, navy bean essence 3-6 part, lactalbumin 8-10 part, isoflavones 2-4 part, l-cn 1.5-2.5 part, Arabinose 3-5 part, hydroxycitric acid 2-4 part, Konjak dietary fiber 0.3-0.8 part and nano zeolite 1.5-2.5 part according to mass fraction.
Further, the present invention is used for the nutrient of weight-reducing, comprises Bee Pollen 6.5 parts, navy bean essence 4.5 parts, lactalbumin 9 parts, isoflavones 3 parts, l-cn 2 parts, Arabinose 4 parts, hydroxycitric acid 3 parts, Konjak dietary fiber 0.5 part and nano zeolite 2 parts according to mass fraction.
Effect of Raw of the present invention is as follows:
(1) Bee Pollen: containing multiple nutrients material in Bee Pollen, comprising two seed amino acid, 14 kinds of vitamins and 30 various trace elements and a large amount of active proteases, nucleic acid, flavone compound and other active material.Bee Pollen can prevent and treat cardiovascular and cerebrovascular disease, reducing blood lipid, adjustment nervous system is anti-ageing, there are obvious anti-cancer tumor suppressor and liver protecting, prevent the functions such as anaemia, diabetes, antifatigue, can internal system be regulated to balance comprehensively, fundamentally improve the vigor of skin, prevent facial pigmentation, pachylosis, aging, make skin keep pure white, glossy, high resilience.Take Bee Pollen in addition and can absorb enough nutrition, cause satietion, meanwhile, the fat of the lecithin incendivity surplus in Bee Pollen, reaches the object of fat-reducing.
(2) navy bean essence: the essence extracted from navy bean is rich in alpha-amylase inhibitor and water-soluble dietary fiber, effectively can block the decomposition of starch in starch food, block the picked-up of most of starch heat, reduce adipose-derived, and do not affect the absorption of other nutriment, can make to need people to lose weight normal diet, body weight does not increase.And alpha-amylase inhibitor is got rid of external through intestines and stomach, without blood circulation, do not act on cerebral nerve maincenter, not weak after edible, apocleisis, body weight do not rebound, meet completely the fat-reducing principle of the World Health Organization.
(3) lactalbumin: a kind of protein extracted in milk, nutritive value is far above various protein, wherein ALA, bovine serum albumin, lactoferrin are rich in cystine residue, cell membrane can be entered safely, synthesis GSH, thus enhancing antioxidant ability of organism, improve the generation of muscular endurance and continuity fatigue.In addition, people takes in lactalbumin and can reduce the serious hope of food and lower Energy intaking.
(4) isoflavones: that extracts from soybean has the phytoestrogen of analog structure with estrogen, its function influence is to estrogen secretion, metabolic biology is active, protein synthesis, growth factor activity, can make that human body skin is smooth, fine and smooth, tender, high resilience, radiate the vigour of youth elegance.Women activates adipose tissue in breast by complementing estrogen, free-fat orientation is made to be attracted to breast, thus reach breast augmentation effect, effects such as there is prevention menopausal syndrome simultaneously, postpone climacteric, delay senility, and coordinate l-cn effectively to be sent in mitochondria by fat to be oxidized, provide certain energy by fat utilization and for human body.
(5) l-cn: be a kind of required coenzyme in fat metabolic process, under hormonal cooperation, can promote that aliphatic acid enters mitochondria and carries out oxidation Decomposition.Mitochondria can burn fat, makes it to release energy, is consumed by health.
(6) Arabinose: extract from the colloid of Arab's tree secretion, scientist and nutritionist have done large quantifier elimination to Arabinose, show through Long-term clinical, the metabolic conversion of Arabinose to sucrose has blocking effect, makes it be used widely in fat-reducing, control diabetes etc.In addition, Arabinose has the effect of promotion bifidobacterium growth in stomach, effectively can promote intestines peristalsis, remove constipation.
The utilizable energy of human body has glucose and two kinds, aliphatic acid, if eat carbohydrate many (comprising starch and carbohydrate-modifying carbohydrate), send glucose to blood in a large number, health does not just consume fat.What that is glucose existed is fewer, and the person more can burn consumption aliphatic acid, and utilizes the mechanism of aliphatic acid more active, also useful burning consumption of glucose.Human body, when lacking glucose, still has gluconeogenesis effect, and gluconeogenesis effect can consume the fat of health.Can be come by acceleration consumption aliphatic acid and gluconeogenesis effect manufacture glucose two links so accelerate fat combustion.
(7) hydroxycitric acid: HCA (hydroxycitric acid) is HCA extract, comes from natural extract, the chemical composition simultaneously having again Western medicine raw material clear and definite and fat-reducing base reason.It promotes the burning of aliphatic acid by the synthesis of fat, reduces the absorption of food.HCA can also stimulate diet maincenter, and allow human body not easily have sense on an empty stomach, appetite can reduce naturally, and without any side effect, does not rebound after fat-reducing.
(8) Konjak dietary fiber: Rhizoma amorphophalli fiber, containing soluble cellulose and the mineral matter such as multivitamin and potassium, phosphorus, selenium, be the more important thing is containing glucomannan.Rhizoma amorphophalli fiber has hypotensive, blood sugar, elimination constipation distending pain, clean stomach, ease constipation, toxin expelling effect.Glucomannan in Rhizoma amorphophalli fiber has powerful expansive force, has the sticky toughness exceeding any one natural plant gum, can fill stomach and intestine, eliminates hunger, therefore can appetite control, reaches the object of defatting beauty.
(9) nano zeolite: zeolite Main Ingredients and Appearance is montmorillonite; but ion-exchanger adsorption capacity is considerably beyond montmorillonite; the zeolite that this formula adopts is the activated modification of pure zeolite; broken through nano ultrafine powders again; there is larger specific area; can effectively adsorb poisonous and harmful substance in stomach, the meagre diaphragm of one deck can be formed simultaneously and stop harmful substance to absorb on stomach wall.The nano zeolite various mineral matter that human body can be provided to need and trace element in addition.
The nutrient difference from prior art that the present invention is used for weight-reducing is:
The equal safe without toxic side effect of raw material of nutrient of the present invention, Arabinose wherein and Konjak dietary fiber can not be immediately used by the body, coordinate the carbohydrate homenergic material that the alpha-amylase inhibitor in navy bean essence and lactalbumin are taken in from Sources controlling, and reduce hydrolysis and the absorption of the starch taken in, thus promote decomposition and the utilization of the fat stored in human body; Fat is sent in mitochondria and is oxidized by isoflavones cooperation l-cn effectively; Hydroxycitric acid promotes that the consumption of fat provides energy for human body on the one hand, stimulates diet maincenter to make people reduce appetite on the other hand; Arabinose promotes the growth of Bifidobacterium in stomach, effectively can promote intestines peristalsis, removes constipation; Nano zeolite has larger specific area, not only can adsorb the harmful substance in stomach and intestine, can also adsorb other raw materials in nutrient of the present invention, reach the object of slow releasing, extends result of use.Therefore, whole nutrition that human body needs can either be provided after nutrient of the present invention is ingested, carbohydrate unnecessary in food and fat can be controlled in right amount again, reach the object of true health fat-reducing, solve all ubiquitous problem of existing diet products.
Detailed description of the invention
By following examples and demonstration test, the nutrient for weight-reducing of the present invention is further described
Embodiment 1
The nutrient for weight-reducing of the present embodiment comprises following raw material:
Embodiment 2
The nutrient for weight-reducing of the present embodiment comprises following raw material:
Embodiment 3
The nutrient for weight-reducing of the present embodiment comprises following raw material:
Embodiment 4
The nutrient for weight-reducing of the present embodiment comprises following raw material:
Embodiment 5
The nutrient for weight-reducing of the present embodiment comprises following raw material:
Each raw material mixing in above embodiment can be obtained the nutrient being used for weight-reducing, and wherein navy bean essence is the navy bean essence Tang not high product that Shanghai Yuan Qiang Industrial Co., Ltd. produces;
Safety testing
For checking the present invention is used for the security of the nutrient of weight-reducing, respectively the nutrient of Example 1-5 and water in mass ratio 1:1 after mixing gavage is carried out to SD system rat and alimentary canal is injected, study the impact of nutrient of the present invention on its blood biochemistry index and alimentary canal tissue.
Get the SD female system rat 32 that body weight is 200g ± 20g, be divided into three groups, negative control group 8, blank group 8, experimental group 8.Experimental group 1mL nutrient water solution gavage 1 time/d, altogether 21d.
Acquired results is as follows:
1, the serum alanine aminotransferase (ALT) of experimental group, serum creatinine (CREA), serum uric acid (uA), total serum protein (TP), seralbumin (ALB), serum globulins (GLOB) are not all higher than the index of Normal group.
2, tissue examination result is, liver kidney, alimentary canal tissue paraffin section de, and HE dyes, microscopic examination, has no distortion infiltration, red and swollen, inflammation.
3, alimentary canal has no cytomorphosis and leukocyte infiltration, redness, hyperemia, hemorrhage, inflammation, festers, without obvious pathological change.
Crowd tests
For checking the present invention is used for the result of use of nutrient of weight-reducing, choose appointment crowd and take the obtained nutrient of the proportioning of embodiment 1-5, each 30g, 1 time/d, 30d altogether.Crowd's result of the test shows, and the nutrient for weight-reducing of the present invention effectively can reduce the body weight of obese people, and non-stimulated to stomach and intestine, can produce ill symptoms.
Exemplary is as follows:
Pan so-and-so, female, 22 years old, height 158cm, body weight 78.1kg; After taking nutrient 30d of the present invention, body weight reduces to 71.2kg, and take period without ill symptomses such as apocleisis, nauseating, diarrhoea, health is good.
Wang, man, 27 years old, height 175cm, body weight 86.3kg, after taking nutrient 30d of the present invention, body weight reduced to 82.5kg, and take period without ill symptomses such as apocleisis, nauseating, diarrhoea, health is good.
Grandson, man, 33 years old, height 177cm, body weight 90.5kg, after taking nutrient 30d of the present invention, body weight reduced to 81.8kg, and take period without ill symptomses such as apocleisis, nauseating, diarrhoea, health is good.
Liu so-and-so, female, 25 years old, height 162cm, body weight 65.5kg, after taking nutrient 30d of the present invention, body weight reduced to 61.5kg, and take period without ill symptomses such as apocleisis, nauseating, diarrhoea, health is good.
Zhao so-and-so, man, 37 years old, height 173cm, body weight 85.2kg, after taking nutrient 30d of the present invention, body weight reduced to 79kg, and take period without ill symptomses such as apocleisis, nauseating, diarrhoea, health is good.
River, man, 30 years old, height 182cm, body weight 94kg, after taking nutrient 30d of the present invention, body weight reduced to 85kg, and take period without ill symptomses such as apocleisis, nauseating, diarrhoea, health is good.
Paddy so-and-so, female, 29 years old, height 160cm, body weight 67kg, after taking nutrient 30d of the present invention, body weight reduced to 60.2kg, and take period without ill symptomses such as apocleisis, nauseating, diarrhoea, health is good.
Although the foregoing describe the specific embodiment of the present invention, it will be understood by those of skill in the art that these only illustrate, protection scope of the present invention is defined by the appended claims.Those skilled in the art, under the prerequisite not deviating from principle of the present invention and essence, can make various changes or modifications to these embodiments, but these change and amendment all falls into protection scope of the present invention.
Claims (3)
1. the nutrient for weight-reducing, it is characterized in that, comprise Bee Pollen 3-10 part, navy bean essence 2-7 part, lactalbumin 6-12 part, isoflavones 1-5 part, l-cn 0.5-3 part, Arabinose 2-6 part, hydroxycitric acid 1-5 part, Konjak dietary fiber 0.1-1 part and nano zeolite 0.5-3 part according to mass fraction.
2. the nutrient for weight-reducing according to claim 1, it is characterized in that, comprise Bee Pollen 5-8 part, navy bean essence 3-6 part, lactalbumin 8-10 part, isoflavones 2-4 part, l-cn 1.5-2.5 part, Arabinose 3-5 part, hydroxycitric acid 2-4 part, Konjak dietary fiber 0.3-0.8 part and nano zeolite 1.5-2.5 part according to mass fraction.
3. the nutrient for weight-reducing according to claim 2, it is characterized in that, comprise Bee Pollen 6.5 parts, navy bean essence 4.5 parts, lactalbumin 9 parts, isoflavones 3 parts, l-cn 2 parts, Arabinose 4 parts, hydroxycitric acid 3 parts, Konjak dietary fiber 0.5 part and nano zeolite 2 parts according to mass fraction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510705682.0A CN105341905A (en) | 2015-10-27 | 2015-10-27 | Nutrient used for reducing weight and slimming |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510705682.0A CN105341905A (en) | 2015-10-27 | 2015-10-27 | Nutrient used for reducing weight and slimming |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105341905A true CN105341905A (en) | 2016-02-24 |
Family
ID=55318183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510705682.0A Pending CN105341905A (en) | 2015-10-27 | 2015-10-27 | Nutrient used for reducing weight and slimming |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105341905A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106605744A (en) * | 2016-08-25 | 2017-05-03 | 西安源森生物科技有限公司 | Composition capable of reducing fat, slimming, expelling toxin and beautifying, as well as preparation method thereof |
| CN106889302A (en) * | 2017-03-08 | 2017-06-27 | 上海新肌生物科技有限公司 | Nanoscale lactalbumin extracting method and formula with slim effect |
| CN108378355A (en) * | 2018-01-06 | 2018-08-10 | 福建古瑞森生物科技有限公司 | Reducing diabetes B patient's postprandial blood sugar improves the alimentation composition pre- before the meal and preparation method thereof that blood fat increases intestinal beneficial bacterium |
| CN109567160A (en) * | 2018-11-29 | 2019-04-05 | 桑植县湘西密码生物科技有限公司 | A kind of slimming capsule and its processing method |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006025769A (en) * | 2004-07-13 | 2006-02-02 | Kosshi:Kk | Health food and method for maintaining health |
| CN101524144A (en) * | 2009-04-16 | 2009-09-09 | 孙吉良 | Konjak food weight-reducing capsule and preparation method thereof |
| CN103230021A (en) * | 2012-08-10 | 2013-08-07 | 广州市赛健生物科技有限公司 | Weight-loss health-care food and preparation method thereof |
| CN103284039A (en) * | 2012-12-27 | 2013-09-11 | 福建永生活力生物工程有限公司 | Weight-reducing composition and preparation method thereof |
| CN104366480A (en) * | 2014-11-28 | 2015-02-25 | 哈尔滨墨医生物技术有限公司 | Lipid-lowering and weight-reducing nutritional meal powder and preparation method thereof |
-
2015
- 2015-10-27 CN CN201510705682.0A patent/CN105341905A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006025769A (en) * | 2004-07-13 | 2006-02-02 | Kosshi:Kk | Health food and method for maintaining health |
| CN101524144A (en) * | 2009-04-16 | 2009-09-09 | 孙吉良 | Konjak food weight-reducing capsule and preparation method thereof |
| CN103230021A (en) * | 2012-08-10 | 2013-08-07 | 广州市赛健生物科技有限公司 | Weight-loss health-care food and preparation method thereof |
| CN103284039A (en) * | 2012-12-27 | 2013-09-11 | 福建永生活力生物工程有限公司 | Weight-reducing composition and preparation method thereof |
| CN104366480A (en) * | 2014-11-28 | 2015-02-25 | 哈尔滨墨医生物技术有限公司 | Lipid-lowering and weight-reducing nutritional meal powder and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 贾利蓉，等: "《保健食品营养》", 30 June 2006 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106605744A (en) * | 2016-08-25 | 2017-05-03 | 西安源森生物科技有限公司 | Composition capable of reducing fat, slimming, expelling toxin and beautifying, as well as preparation method thereof |
| CN106889302A (en) * | 2017-03-08 | 2017-06-27 | 上海新肌生物科技有限公司 | Nanoscale lactalbumin extracting method and formula with slim effect |
| CN108378355A (en) * | 2018-01-06 | 2018-08-10 | 福建古瑞森生物科技有限公司 | Reducing diabetes B patient's postprandial blood sugar improves the alimentation composition pre- before the meal and preparation method thereof that blood fat increases intestinal beneficial bacterium |
| CN109567160A (en) * | 2018-11-29 | 2019-04-05 | 桑植县湘西密码生物科技有限公司 | A kind of slimming capsule and its processing method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102106498B (en) | Weight losing meal-replacing powder | |
| CN102805266B (en) | Feed for improving digestive and immunologic ability of chicken | |
| CN106983136A (en) | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof | |
| CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
| CN108142803A (en) | Full nutrition coarse food grain | |
| CN108523122A (en) | A kind of weight losing meal-replacing powder | |
| CN103404865B (en) | Nutritional meal replacement powder with effect of reducing weight and fat and preparation method thereof | |
| CN108272078A (en) | Special medicine purposes formula food meal replacement powder of control body weight and preparation method thereof | |
| CN106942748A (en) | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof | |
| CN105341905A (en) | Nutrient used for reducing weight and slimming | |
| CN107373672A (en) | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof | |
| CN106418501A (en) | Healthcare food with weight reducing function | |
| CN107440102A (en) | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof | |
| CN110214942A (en) | A kind of hyperthyroidism tailored version Nutrition formula and preparation method thereof | |
| CN100482085C (en) | Method for preparing soymilk powder contg. micron ginseng and antler etc. with tonifying-kidney and eliminating fatigue functions | |
| CN107136490A (en) | A kind of peptide Chinese caterpillar fungus health product | |
| CN103798596B (en) | Total nutrient formula food suitable for patients with cardiovascular and cerebrovascular diseases | |
| CN108095075A (en) | Miscarriage women tailored version clinical nutrition formula and preparation method thereof | |
| CN100333652C (en) | Method for preparing milk powder contg. micron ginseng and antler etc. with tonifying-kidney and eliminating fatigue functions | |
| CN104187725A (en) | Convenient food for conditioning colorectal neoplasms | |
| CN100399917C (en) | Method for preparing milk tablets contg micron ginseng and antler etc. with tonifying-kidney and eliminating-fatigue functions | |
| CN100370908C (en) | Method for preparing kidney-replenishing health-preserving soybean milk powder with micron antler powder, tortoise plastron powder, curculigo rhizome powder, walnut kernel powder, dried solomonseal po | |
| RU2403805C1 (en) | Dietary and prophylactic food product for regeneration of reproductive functions of males and females | |
| CN1331407C (en) | Method for preparing contg. micron ginseng and antler etc. with tonifying-kidney and eliminating-fatigue functions | |
| CN110200273A (en) | A kind of clinical liver disease nutritious food and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160224 |
|
| RJ01 | Rejection of invention patent application after publication |